Search results for the GEO ID: GSE17119
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM428146
GPL570
Control cells, 1 h post-supplementation. Human microvascular endothelial cells (HMVEC), 1 h post-supplementation with 0.6% dimethyl sulfoxide (DMSO) vehicle control. cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 0.6% dimethyl sulfoxide (DMSO) vehicle control was added to the sample. Total RNA from the cultures was isolated 1 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428147
GPL570
Control cells, 2 h post-supplementation. Human microvascular endothelial cells (HMVEC), 2 h post-supplementation with 0.6% dimethyl sulfoxide (DMSO) vehicle control. cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 0.6% dimethyl sulfoxide (DMSO) vehicle control was added to the sample. Total RNA from the cultures was isolated 2 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428148
GPL570
Control cells, 4 h post-supplementation. Human microvascular endothelial cells (HMVEC), 4 h post-supplementation with 0.6% dimethyl sulfoxide (DMSO) vehicle control. cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 0.6% dimethyl sulfoxide (DMSO) vehicle control was added to the sample. Total RNA from the cultures was isolated 4 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428149
GPL570
Control cells, 8 h post-supplementation. Human microvascular endothelial cells (HMVEC), 8 h post-supplementation with 0.6% dimethyl sulfoxide (DMSO) vehicle control. cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 0.6% dimethyl sulfoxide (DMSO) vehicle control was added to the sample. Total RNA from the cultures was isolated 8 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428150
GPL570
Control cells, 16 h post-supplementation. Human microvascular endothelial cells (HMVEC), 16 h post-supplementation with 0.6% dimethyl sulfoxide (DMSO) vehicle control. cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 0.6% dimethyl sulfoxide (DMSO) vehicle control was added to the sample. Total RNA from the cultures was isolated 16 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428151
GPL570
Control cells, 24 h post-supplementation. Human microvascular endothelial cells (HMVEC), 24 h post-supplementation with 0.6% dimethyl sulfoxide (DMSO) vehicle control. cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 0.6% dimethyl sulfoxide (DMSO) vehicle control was added to the sample. Total RNA from the cultures was isolated 24 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428152
GPL570
Control cells, 48 h post-supplementation. Human microvascular endothelial cells (HMVEC), 48 h post-supplementation with 0.6% dimethyl sulfoxide (DMSO) vehicle control. cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 0.6% dimethyl sulfoxide (DMSO) vehicle control was added to the sample. Total RNA from the cultures was isolated 48 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428153
GPL570
PNF1-treated cells, 1 h post-supplementation. Human microvascular endothelial cells (HMVEC), 1 h post-supplementation with 30 µM phthalimide neovascular factor 1 (PNF1). cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 30 µM PNF1 was added to the sample. Total RNA from the cultures was isolated 1 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428154
GPL570
PNF1-treated cells, 2 h post-supplementation. Human microvascular endothelial cells (HMVEC), 2 h post-supplementation with 30 µM phthalimide neovascular factor 1 (PNF1). cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 30 µM PNF1 was added to the sample. Total RNA from the cultures was isolated 2 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428155
GPL570
PNF1-treated cells, 4 h post-supplementation. Human microvascular endothelial cells (HMVEC), 4 h post-supplementation with 30 µM phthalimide neovascular factor 1 (PNF1). cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 30 µM PNF1 was added to the sample. Total RNA from the cultures was isolated 4 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428156
GPL570
PNF1-treated cells, 8 h post-supplementation. Human microvascular endothelial cells (HMVEC), 8 h post-supplementation with 30 µM phthalimide neovascular factor 1 (PNF1). cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 30 µM PNF1 was added to the sample. Total RNA from the cultures was isolated 8 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428157
GPL570
PNF1-treated cells, 16 h post-supplementation. Human microvascular endothelial cells (HMVEC), 16 h post-supplementation with 30 µM phthalimide neovascular factor 1 (PNF1). cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 30 µM PNF1 was added to the sample. Total RNA from the cultures was isolated 16 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428158
GPL570
PNF1-treated cells, 24 h post-supplementation. Human microvascular endothelial cells (HMVEC), 24 h post-supplementation with 30 µM phthalimide neovascular factor 1 (PNF1). cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 30 µM PNF1 was added to the sample. Total RNA from the cultures was isolated 24 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
GSM428159
GPL570
PNF1-treated cells, 48 h post-supplementation. Human microvascular endothelial cells (HMVEC), 48 h post-supplementation with 30 µM phthalimide neovascular factor 1 (PNF1). cell line: HMVEC HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm^2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 30 µM PNF1 was added to the sample. Total RNA from the cultures was isolated 48 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes